Skip to main content
NewslettersWatchlist

Appili Therapeutics Inc(APLI-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.0300
Day High0.0350
Open:0.0300
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.
GlobeNewswire
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
GlobeNewswire
Appili Therapeutics Announces Results of Special Meeting of Shareholders
AllPennyStocks.com
Biopharma Bucking Market Trends on Positive FDA Feedback
GlobeNewswire
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
AI-generated - The Globe and Mail
Appili Therapeutics: Top 10 Undervalued Biotechnology Industry Stocks (APLI)
GlobeNewswire
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024

Profile

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.